Shares of Hologic Inc. (HOLX) are up 2.68% to $31.58 in mid-day trading Thursday, after analysts at Canaccord Genuity upgraded their rating on the name to ‘Buy’ from ‘Hold’. The firm believes there is another leg of upside ahead for HOLX, driven by improving top-line growth and operating efficiencies. The target price has been set to $37.00 from $29.00.
On valuation measures, Hologic Inc. shares are currently priced at 175.67x this year’s forecasted earnings compared to the industry’s 28.41x earnings multiple. Ticker has a PEG and forward P/E ratio of 2.47 and 18.44, respectively. Price/Sales for the same period is 3.39 while EPS is $0.18. Currently there are 11 analysts that rate HOLX a ‘Buy’, 8 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. HOLX has a median Wall Street price target of $32.25 with a high target of $35.00.
Hologic Inc’s shares closed at $30.83 Wednesday. Canaccord’s target price suggests a potential upside of about 17% from the name’s current price of $31.70.
Shares are up 42.47% year-over-year, and 15.30% year-to-date.
Shares of Garmin Ltd. (GRMN) are fractionally higher in midday trading Thursday, after Bank of America (BAC) upgraded the stock with a ‘Buy’ from ‘Neutral’ rating. The move comes on a massive volume too with the issue trading more than 3.2 million shares, compared to the average volume of 1.49 million.
GRMN shares recently gained $0.39, or 0.77%, to $51.10. The stock is up more than 11.23% year-over-year and has lost roughly 4% year-to-date. In the past 52 weeks, shares of El Segundo, California-based company have traded between a low of $48.67 and a high of $62.05.
Garmin Ltd. closed Wednesday at $50.71. The name has a total market cap of $9.77B.
Shares of Monster Worldwide, Inc. (MWW) rallied 5.13% on Thursday after an upgrade to ‘Buy’ from ‘Hold’ at Evercore. The move comes on a big volume too with the issue now trading more than 3 million shares, compared to the average volume of 1.7 million shares. MWW began trading this morning at $6.24 to currently trade up $0.28 from the prior days close of $5.95. On an intraday basis it got as low as $6.17 and as high as $6.64.
Monster Worldwide is down more than 21% year-over-year, and has gained roughly 29% year-to-date.
Sanofi (SNY) shares are up 1.24% to $49.86 on Thursday after being upgraded to ‘Buy’ from ‘Neutral’ at BofA/Merrill (BAC).
On valuation measures, Sanofi shares are currently priced at 26.21x this year’s forecasted earnings compared to the industry’s 2.49x earnings multiple. Ticker has a PEG and forward P/E ratio of 3.41 and 15.66, respectively. Price/Sales for the same period is 3.33 while EPS is $1.90. Currently there are 9 analysts that rate SNY a ‘Buy’, 17 rate it a ‘Hold’. 1 analyst rates it a ‘Sell’. SNY has a median Wall Street price target of $48.61 with a high target of $59.00.
In the past 52 weeks, shares of the Paris, France-based company have traded between a low of $43.57 and a high of $57.42. Shares are up 1.21% year-over-year, and 7.98% year-to-date.
Deutsche Bank (DB) is out with a report this morning upgrading shares of Valero Energy Corporation (VLO) with a ‘Buy’ from ‘Hold’ rating.
VLO shares recently gained $1.03 to $60.30. The stock is up more than 19.50% year-over-year and has gained roughly 20.61% year-to-date. In the past 52 weeks, shares of San Antonio, Texas-based petroleum refiner have traded between a low of $42.53 and a high of $60.68.
Valero Energy Corporation closed Wednesday at $59.27. Ticker has a total market cap of $31.43 billion.